VANGUARD CAPITAL MANAGEMENT LLC
Position in CATX — Perspective Therapeutics, Inc.
CIK 2100119
MALVERN, PA
Position in CATX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,128,710
-$3,131,536 QoQ
Shares Held
4,436,572
+1.3% QoQ
Ownership
3.89%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 130 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026VANGUARD CAPITAL MANAGEMENT LLC holds $42,477,438,602 across 118 Medical Devices names. CATX ranks #52 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
113,750,994 | $10,321,765,195 | |
| 2 | SYK |
Stryker Corp
|
22,536,843 | $7,095,499,650 | |
| 3 | MDT |
Medtronic plc
|
83,816,735 | $6,556,983,179 | |
| 4 | BSX |
Boston Scientific Corp
|
97,087,553 | $4,143,696,762 | |
| 5 | EW |
Edwards Lifesciences Corp
|
37,615,952 | $3,402,739,017 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
29,724,359 | $1,902,656,219 | |
| 7 | DXCM |
Dexcom Inc
|
25,209,752 | $1,697,876,797 | |
| 8 | STE |
STERIS plc
|
6,406,906 | $1,349,102,196 |
All Filings in CATX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,128,710 | 4,436,572 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $18,260,246 | 4,378,956 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||